ASH Logo

Ashland Inc. (ASH) 

NYSE
Market Cap
$4.25B
Sector
Basic Materials
Industry
Chemicals—Specialty
Rank in Sector
51 of 124
Rank in Industry
19 of 48

Largest Insider Buys in Sector

ASH Stock Price History Chart

ASH Stock Performance

About Ashland Inc.

Ashland Inc. provides additives and specialty ingredients worldwide. It operates through Life Sciences; Personal Care & Household; Specialty Additives; and Intermediates and Solvents segments. The Life Sciences segment offers pharmaceutical solutions, including controlled release polymers, disintegrants, tablet coatings, thickeners, solubilizers, and tablet binders; nutrition solutions, such as thickeners, stabilizers, emulsifiers, and additives; and nutraceutical solutions comprising products for weight management, joint comfort, stomach and …

Insider Activity of Ashland Inc.

Over the last 12 months, insiders at Ashland Inc. have bought $0 and sold $629,748 worth of Ashland Inc. stock.

On average, over the past 5 years, insiders at Ashland Inc. have bought $18.95M and sold $59.63M worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 224,156 shares for transaction amount of $22.46M was made by Sandler Ricky C (See Remarks) on 2022‑09‑01.

List of Insider Buy and Sell Transactions, Ashland Inc.

2024-09-04SaleSVP and CFO
5,487
0.0112%
$87.88$482,198-1.81%
2024-02-16SaleSVP, Gen Counsel and Secrty.
844
0.0017%
$92.54$78,104+3.44%
2023-12-07SalePrincipal Accounting Officer
843
0.0016%
$82.38$69,446+11.28%
2023-09-05SaleSr.VP &Chief Financial Officer
7,866
0.0155%
$86.54$680,724+4.28%
2022-09-01SaleSee Remarks
224,156
0.415%
$100.20$22.46M-0.44%
2022-09-01Sale
224,156
0.415%
$100.20$22.46M-0.44%
2022-09-01PurchaseSee Remarks
224,156
0.415%
$100.20$22.46M-0.44%
2022-09-01Purchase
224,156
0.415%
$100.20$22.46M-0.44%
2022-06-08SalePrincipal Accounting Officer
2,657
0.0049%
$109.50$290,942-5.29%
2022-06-07SalePrincipal Accounting Officer
2,657
0.0049%
$109.50$290,942-6.83%
2022-06-02SaleSr.VP &Chief Financial Officer
4,235
0.0077%
$105.58$447,131-4.36%
2022-06-01SaleSr.VP &Chief Financial Officer
2,374
0.0044%
$105.58$250,647-2.08%
2022-05-17PurchaseSee Remarks
48,800
0.0901%
$101.27$4.94M+2.28%
2022-05-17Purchase
48,800
0.0901%
$101.27$4.94M+2.28%
2021-09-10SaleChief Financial Officer
2,208
0.0039%
$94.30$208,214+8.89%
2021-06-03SalePrincipal Accounting Officer
4,858
0.008%
$93.88$456,069+2.19%
2020-12-28SaleChief Financial Officer
8,148
0.0137%
$80.00$651,840+13.50%
2020-11-30SaleSenior Vice President
5,098
0.0085%
$75.93$387,091+17.68%
2020-11-24PurchaseSr VP & Gen Mgr, Life Sciences
200
0.0003%
$77.88$15,576+14.77%
2020-11-18SaleChief Financial Officer
4,404
0.0075%
$80.00$352,320+13.56%

Insider Historical Profitability

2.19%
EMINENCE CAPITAL, LP
4083978
8.3633%
$86.9721+0.92%
Sandler Ricky CSee Remarks
4083978
8.3633%
$86.9722+0.92%
NOVO GUILLERMOChairman and CEO
12900
0.0264%
$86.9710<0.0001%
KALYANA SWAMINATHAN ASHOKSr VP & Gen Mgr, Life Sciences
100
0.0002%
$86.9710+14.77%

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
The Vanguard Group$470.78M9.654.83M-2.71%-$13.14M0.01
BlackRock$440.77M9.034.53M+1.99%+$8.62M0.01
Eminence Capital LP$319.9M6.553.29M-6.56%-$22.44M5.87
Dimensional Fund Advisors$261.55M5.362.69M+1.05%+$2.72M0.07
Massachusetts Financial Services Co Ma$205.98M4.222.12M-12.76%-$30.12M0.06
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.